Results 191 to 200 of about 273,619 (385)
Abstract Objectives Determining etiology for adults with symptoms of lower respiratory tract infection (LRTI) is challenging. MeMed BV (MMBV), an FDA‐cleared blood test, computationally integrates the levels of three host proteins to differentiate bacterial and viral infections.
Adam J. Singer+14 more
wiley +1 more source
Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications. [PDF]
Á. J. Geirsson+2 more
openalex +1 more source
COVID-19 vasculitis and novel vasculitis mimics
D. McGonagle+4 more
semanticscholar +1 more source
Zosteriform Primary Cutaneous Marginal Zone Lymphoma—A Case Report
ABSTRACT We report a case of zosteriform PCMZL presenting in a T3–T4 dermatomal distribution not previously described in the literature. Although the varicella zoster virus was not detected in this case, late diagnosis of the acute eruption of zoster or even preceding zoster ‘sine herpete’ cannot be excluded as antigenic triggers.
Natalie Teh+4 more
wiley +1 more source
MOv18 IgE, the first‐in‐class IgE antibody targeting the cancer antigen folate receptor alpha (FR⍺) showed early signs of efficacy and was well tolerated in a first‐in‐human clinical trial, with transient urticarial skin reactions as the most common toxicity.
Chara Stavraka+28 more
wiley +1 more source
Bilateral necrotising scleritis with marginal corneal ulceration after cataract surgery in a patient with vasculitis. [PDF]
Stephen E. Bloomfield+3 more
openalex +1 more source
T cell receptor repertoire analysis by high‐throughput immune repertoire RNA‐sequencing in the patients with DOCK8 deficiency. Comprehensive comparisons revealed a restricted TCR repertoire diversity in the patients. Additional assessments showed potential auto‐reactive CD8+ T cell clones in the patients.Abbreviations: DOCK8, dedicator of cytokinesis ...
Ceren Bozkurt+26 more
wiley +1 more source
Patchy Alopecia, Anhidrosis, Eccrine Gland Wall Hypertrophy and Vasculitis
I. Sárkány
openalex +1 more source
MEPOLYP was a pooled analysis of 1037 patients with SAEP[±]CRSwNP. Mepolizumab was associated with a reduction in CSEs, OCS use, and BEC, and improved lung function and ACT score. Over 47% of patients fulfilled ≥ 3 clinical remission criteria. When compared, there was a 30.0% incremental benefit of mepolizumab in reducing CSEs for patients with SAEP ...
Florence Schleich+14 more
wiley +1 more source